Purdue Pharma reports $13 million operating profit for July, cash up

By Sarah Lizee

Olympia, Wash., Aug. 24 – Purdue Pharma LP reported a $13 million operating profit for July on $50 million of net sales, according to its monthly operating report filed with the U.S. Bankruptcy Court for the Southern District of New York.

To compare, the company reported a $22 million operating profit on $60 million in net sales for June.

The net profit for July was $5 million, compared to a net profit for June of $8 million.

The company listed $877 million in cash and cash equivalents at the end of July, up from $863 million as of June 30.

Purdue Pharma is a Stamford, Conn.-based drug manufacturer. It filed for Chapter 11 bankruptcy on Sept. 15, 2019 under case number 19-23649.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.